Cargando…
MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression
Identification of additional cancer-associated genes and secondary mutations driving the metastatic progression in pheochromocytoma and paraganglioma (PPGL) is important for subtyping, and may provide optimization of therapeutic regimens. We recently reported novel recurrent nonsynonymous mutations...
Autores principales: | Tomić, Tajana Tešan, Olausson, Josefin, Rehammar, Anna, Deland, Lily, Muth, Andreas, Ejeskär, Katarina, Nilsson, Staffan, Kristiansson, Erik, Wassén, Ola Nilsson, Abel, Frida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329139/ https://www.ncbi.nlm.nih.gov/pubmed/32511227 http://dx.doi.org/10.1371/journal.pgen.1008803 |
Ejemplares similares
-
Prevalence of Germline Mutations in Patients with Pheochromocytoma or Abdominal Paraganglioma and Sporadic Presentation: A Population-Based Study in Western Sweden
por: Muth, Andreas, et al.
Publicado: (2012) -
A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma
por: Tomić, Tajana Tešan, et al.
Publicado: (2017) -
Correction: A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma
por: Tomić, Tajana Tešan, et al.
Publicado: (2017) -
Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma
por: Karakaya, Sinan, et al.
Publicado: (2023) -
Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
por: Kluckova, Katarina, et al.
Publicado: (2018)